1. Home
  2. RVMD vs STN Comparison

RVMD vs STN Comparison

Compare RVMD & STN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • STN
  • Stock Information
  • Founded
  • RVMD 2014
  • STN 1954
  • Country
  • RVMD United States
  • STN Canada
  • Employees
  • RVMD N/A
  • STN N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • STN Military/Government/Technical
  • Sector
  • RVMD Health Care
  • STN Consumer Discretionary
  • Exchange
  • RVMD Nasdaq
  • STN Nasdaq
  • Market Cap
  • RVMD 8.7B
  • STN 9.2B
  • IPO Year
  • RVMD 2020
  • STN N/A
  • Fundamental
  • Price
  • RVMD $44.06
  • STN $79.38
  • Analyst Decision
  • RVMD Strong Buy
  • STN
  • Analyst Count
  • RVMD 12
  • STN 0
  • Target Price
  • RVMD $64.67
  • STN N/A
  • AVG Volume (30 Days)
  • RVMD 2.2M
  • STN 120.6K
  • Earning Date
  • RVMD 11-06-2024
  • STN 11-07-2024
  • Dividend Yield
  • RVMD N/A
  • STN 0.78%
  • EPS Growth
  • RVMD N/A
  • STN 6.58
  • EPS
  • RVMD N/A
  • STN 2.27
  • Revenue
  • RVMD $742,000.00
  • STN $4,167,733,814.00
  • Revenue This Year
  • RVMD N/A
  • STN $15.93
  • Revenue Next Year
  • RVMD $1,855.42
  • STN $9.42
  • P/E Ratio
  • RVMD N/A
  • STN $35.01
  • Revenue Growth
  • RVMD N/A
  • STN 13.64
  • 52 Week Low
  • RVMD $25.93
  • STN $76.03
  • 52 Week High
  • RVMD $62.40
  • STN $88.42
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 32.07
  • STN 31.24
  • Support Level
  • RVMD $44.50
  • STN $84.27
  • Resistance Level
  • RVMD $46.15
  • STN $85.37
  • Average True Range (ATR)
  • RVMD 1.89
  • STN 1.33
  • MACD
  • RVMD -0.58
  • STN -0.81
  • Stochastic Oscillator
  • RVMD 19.95
  • STN 2.69

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. The company is geographically diversified in three regional operating units namely Canada, United States and Global, offering similar services across all regions. The company offers services in various sectors across the project life cycle through five business operating units infrastructure, water, buildings, environmental services, and energy and resources. The company provides professional services in all phases of the project life cycle: planning, design, construction administration, commissioning, maintenance, decommissioning, and remediation.

Share on Social Networks: